Testosterone abuse and affective disorders

Journal of Substance Abuse Treatment

Volumn 18, Issue 2, 2000, Pages 179-184

  Rashid, Wasim ^a  

^a N Shore Long Isl Jewish Hlth S ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; LITHIUM CARBONATE; TESTOSTERONE; VALPROIC ACID;

ADULT; AFFECTIVE NEUROSIS; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DISEASE COURSE; DRUG ABUSE; DRUG USE; HUMAN; MALE; MENTAL DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; GONADAL STEROID HORMONES; HUMANS; MALE; MOOD DISORDERS; PSYCHOTHERAPY; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; TESTOSTERONE; TREATMENT OUTCOME;

EID: 0034050951     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0740-5472(99)00023-9     Document Type: Article

References (24)

1. Anabolic Steroids: A Threat to Body and Mind. (1996). NIDA Research Report Series, NIH Publication No. 96-3721.
2. Boje O. Doping. Bulletin of the Health Organization of the League of Nations. 8:1939;439-469.
3. Brower K.J., Blow F.C., Beresford T.P., Fuelling C. Anabolic-androgenic steroid dependence. Journal of Clinical Psychiatry. 50:1989;31-33.
4. Brown-Sequard, C. E. (1889). Des effets produits chez l'homme par des injections sous-cutaneé du'un liquide retiré des testicules frais de cobaye et de chien.
5. Choi P.Y.L., Parrott A.C., Cowan D. High-dose anabolic steroids in strength athletes. effects upon hostility and aggression Human Psychopharmacology. 5:1990;349-356.
6. Cigolini M., Targher G., Bergamo Andreis I.A., Tonoli M., Filippi F., Muggeo M., De Sandre G. Moderate alcohol consumption and its relation to visceral fat and plasma androgens in healthy women. International Journal of Obesity and Related Metabolic Disorders. 20:1996;206-212.
7. Clancy G.P., Yates W.R. Anabolic steroid use among substance abusers in treatment. Journal of Clinical Psychiatry. 53:1992;97-100.
8. Duchaine D. Underground Steroid Handbook II. 1989;HLR Technical Books, Venice, CA.
9. Fahrig R. Anti-mutagenic agents are also co-recombinogenic and can be converted into co-mutagens. Mutation Research. 350:1996;59-67.
10. Guirdham A. Treatment of mental disorders with male sex hormone. British Journal of Medicine. 1:1940;10-12.
11. Leckman J.F., Scahill L. Possible exacerbation of tics by androgenic steroids. New England Journal of Medicine. 322:1990;1674.
12. Lefavi R.G., Reeve T.G., Newland M.C. Relationship between anabolic steroid use and selected psychological parameters in male bodybuilders. Journal of Sport Behavior (University of Alabama). 13:1990;157-166.
13. Lombardo J.A. Anabolic-androgenic steroids. NIDA Research Monographs. 102:1990;60-73.
14. Lombardo J.A., Sickles R.T. Medical and performance-enhancing effects of anabolic steroids. Psychiatric Annals. 22:1992;19-23.
15. Malone D.A. Jr., Dimeff R.J., Lombardo J.A., Sample R.H. Psychiatric effects and psychoactive substance use in anabolic-androgenic steroid users. Clinical Journal of Sports Medicine. 5:1995;25-31.
16. Perry P.J., Yates W.R., Andersen K.H. Psychiatric symptoms associated with anabolic steroids. a controlled retrospective study Annals of Clinical Psychiatry. 2:1990;11-17.
17. Pope H.G. Jr., Katz D.L. Affective and psychotic symptoms associated with anabolic steroid use. American Journal of Psychiatry. 145:1988;487-490.
18. Pope H.G. Jr., Katz D.L. Psychiatric effects of anabolic steroids. Psychiatric Annals. 22:1992;24-29.
19. Rabkin J.G., Rabkin R. Testosterone replacement therapy for HIV-infected men. The AIDS Reader. 5:1995;136-144.
20. Tec L. Durabolin in anorexia nervosa. American Journal of Psychiatry. 120:1963;282-283.
21. Wadler, G. I., & Hainline, B. (1989). Drugs and the athlete. In A. Ryan (Ed.), Contemporary Exercise and Sports Medicine Series. Philadelphia: Davis and Company.
22. Yates W.R., Perry P.J., Andersen K.H. Illicit anabolic steroid use. a controlled personality study Acta Psychiatrica Scandinavia. 81:1990;548-550.
23. Yesalis C.E. Epidemiology and patterns of anabolic-androgenic steroid use. Psychiatric Annals. 22:1992;8.
24. Zafirau W., Parker D., Billotte W., Bajpai P.K. Development of a ceramic device for the continuous local delivery of steroids. Biomedical Sciences Instrumentation. 32:1996;63-70.